Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 67Terminated 11Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

pembrolizumab 85Specimen Handling 78Carboplatin 73Magnetic Resonance Spectroscopy 70Biopsy 58Nivolumab 55Cisplatin 54Paclitaxel 46Cyclophosphamide 45durvalumab 37Radiotherapy 37Radiation 36olaparib 34Rituximab 34Etoposide 34Dexamethasone 33Ipilimumab 30Gemcitabine 30Doxorubicin 29Lenalidomide 28Taxes 27Docetaxel 27Pemetrexed 25Bevacizumab 24Prednisone 23Cytarabine 23X-Rays 22Vincristine 21Trastuzumab 21cabozantinib 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Has results × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT03600350 2026-06-01

pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer

University of Wisconsin, Madison

Phase 2 Active not recruiting
19 enrolled 10 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡